Crossmark

Sotagliflozin Reduces HF Events in T2DM Regardless of Baseline Characteristics, Including HF, CKD and LVEF

Crossref DOI link: https://doi.org/10.1007/s10557-021-07203-0

Published Online: 2021-06-28

Published Print: 2021-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Li-Min

Ding, Liang-Liang https://orcid.org/0000-0003-0374-2539
Zhan, Ze-Lin

Qiu, Mei https://orcid.org/0000-0001-5013-657X
License Information

Text and Data Mining valid from 2021-06-28

Version of Record valid from 2021-06-28
More Information

Article History

Accepted: 13 May 2021

First Online: 28 June 2021

Declarations

:

: All authors disclose that they have no conflicts of interest.